IDEXX Laboratories, Inc. (IDXX)
USD 404.65
(3.51%)
USD 404.65
(3.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 622.88 Million USD | -10.3% |
| 2022 | 694.38 Million USD | -10.43% |
| 2021 | 775.2 Million USD | -9.7% |
| 2020 | 858.49 Million USD | 22.83% |
| 2019 | 698.91 Million USD | 16.22% |
| 2018 | 601.34 Million USD | -0.78% |
| 2017 | 606.07 Million USD | 2.19% |
| 2016 | 593.11 Million USD | -0.67% |
| 2015 | 597.08 Million USD | 70.6% |
| 2014 | 350 Million USD | 132.78% |
| 2013 | 150.35 Million USD | 10686.15% |
| 2012 | 1.39 Million USD | -44.26% |
| 2011 | 2.5 Million USD | -26.83% |
| 2010 | 3.41 Million USD | -20.16% |
| 2009 | 4.28 Million USD | -15.96% |
| 2008 | 5.09 Million USD | -11.05% |
| 2007 | 5.72 Million USD | -11.17% |
| 2006 | 6.44 Million USD | 182.59% |
| 2005 | -7.8 Million USD | -2091.33% |
| 2004 | 392 Thousand USD | -50.13% |
| 2003 | 786 Thousand USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 300 Thousand USD | -92.86% |
| 1998 | 4.2 Million USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 524.75 Million USD | 0.0% |
| 2024 Q2 | 524.74 Million USD | -27.59% |
| 2024 Q1 | 724.65 Million USD | 16.34% |
| 2023 Q4 | 622.88 Million USD | 0.66% |
| 2023 FY | 622.88 Million USD | -10.3% |
| 2023 Q3 | 618.81 Million USD | -11.2% |
| 2023 Q2 | 696.84 Million USD | 0.07% |
| 2023 Q1 | 696.36 Million USD | 0.28% |
| 2022 Q1 | 863.01 Million USD | 11.33% |
| 2022 Q4 | 694.38 Million USD | -18.68% |
| 2022 FY | 694.38 Million USD | -10.43% |
| 2022 Q3 | 853.94 Million USD | 11.19% |
| 2022 Q2 | 767.99 Million USD | -11.01% |
| 2021 Q2 | 780.07 Million USD | -8.97% |
| 2021 FY | 775.2 Million USD | -9.7% |
| 2021 Q4 | 775.2 Million USD | -10.66% |
| 2021 Q3 | 867.74 Million USD | 11.24% |
| 2021 Q1 | 856.94 Million USD | -0.18% |
| 2020 Q4 | 858.49 Million USD | -7.09% |
| 2020 FY | 858.49 Million USD | 22.83% |
| 2020 Q3 | 923.97 Million USD | -4.56% |
| 2020 Q2 | 968.15 Million USD | 26.94% |
| 2020 Q1 | 762.7 Million USD | 9.13% |
| 2019 Q3 | 762.97 Million USD | -0.9% |
| 2019 FY | 698.91 Million USD | 16.22% |
| 2019 Q4 | 698.91 Million USD | -8.4% |
| 2019 Q2 | 769.88 Million USD | 0.21% |
| 2019 Q1 | 768.28 Million USD | 27.76% |
| 2018 FY | 601.34 Million USD | -0.78% |
| 2018 Q4 | 601.34 Million USD | -0.18% |
| 2018 Q3 | 602.41 Million USD | -0.12% |
| 2018 Q2 | 603.13 Million USD | -0.96% |
| 2018 Q1 | 609 Million USD | 0.48% |
| 2017 Q1 | 594.86 Million USD | 0.3% |
| 2017 FY | 606.07 Million USD | 2.19% |
| 2017 Q4 | 606.07 Million USD | 0.32% |
| 2017 Q3 | 604.14 Million USD | 0.54% |
| 2017 Q2 | 600.89 Million USD | 1.01% |
| 2016 Q4 | 593.11 Million USD | -1.01% |
| 2016 Q3 | 599.13 Million USD | 0.2% |
| 2016 FY | 593.11 Million USD | -0.67% |
| 2016 Q2 | 597.95 Million USD | -0.34% |
| 2016 Q1 | 600.02 Million USD | 0.49% |
| 2015 Q3 | 599.55 Million USD | 0.11% |
| 2015 Q4 | 597.08 Million USD | -0.41% |
| 2015 Q2 | 598.92 Million USD | 19.79% |
| 2015 FY | 597.08 Million USD | 70.6% |
| 2015 Q1 | 500 Million USD | 42.86% |
| 2014 Q4 | 350 Million USD | 0.0% |
| 2014 Q1 | 150.09 Million USD | -0.18% |
| 2014 FY | 350 Million USD | 132.78% |
| 2014 Q3 | 350 Million USD | 133.33% |
| 2014 Q2 | 150 Million USD | -0.06% |
| 2013 Q1 | 1.14 Million USD | -18.15% |
| 2013 Q3 | 624 Thousand USD | -29.41% |
| 2013 Q4 | 150.35 Million USD | 23995.99% |
| 2013 FY | 150.35 Million USD | 10686.15% |
| 2013 Q2 | 884 Thousand USD | -22.52% |
| 2012 FY | 1.39 Million USD | -44.26% |
| 2012 Q1 | 2.26 Million USD | -9.52% |
| 2012 Q2 | 2.02 Million USD | -10.69% |
| 2012 Q4 | 1.39 Million USD | -21.51% |
| 2012 Q3 | 1.77 Million USD | -12.12% |
| 2011 Q1 | 3.19 Million USD | -6.55% |
| 2011 FY | 2.5 Million USD | -26.83% |
| 2011 Q4 | 2.5 Million USD | -8.56% |
| 2011 Q3 | 2.73 Million USD | -7.79% |
| 2011 Q2 | 2.96 Million USD | -7.14% |
| 2010 Q3 | 3.63 Million USD | -5.63% |
| 2010 FY | 3.41 Million USD | -20.16% |
| 2010 Q4 | 3.41 Million USD | -6.07% |
| 2010 Q2 | 3.85 Million USD | -5.26% |
| 2010 Q1 | 4.07 Million USD | -4.93% |
| 2009 Q4 | 4.28 Million USD | -94.93% |
| 2009 FY | 4.28 Million USD | -15.96% |
| 2009 Q3 | 84.48 Million USD | -0.24% |
| 2009 Q2 | 84.69 Million USD | 1629.86% |
| 2009 Q1 | 4.89 Million USD | -3.89% |
| 2008 Q4 | 5.09 Million USD | -1.22% |
| 2008 Q3 | 5.15 Million USD | -3.61% |
| 2008 Q2 | 5.35 Million USD | -3.43% |
| 2008 Q1 | 5.54 Million USD | -3.27% |
| 2008 FY | 5.09 Million USD | -11.05% |
| 2007 Q4 | 5.72 Million USD | -3.11% |
| 2007 FY | 5.72 Million USD | -11.17% |
| 2007 Q2 | 6.09 Million USD | -2.85% |
| 2007 Q3 | 5.91 Million USD | -2.97% |
| 2007 Q1 | 6.27 Million USD | -2.73% |
| 2006 FY | 6.44 Million USD | 182.59% |
| 2006 Q1 | -7.17 Million USD | 8.1% |
| 2006 Q2 | 6.79 Million USD | 194.72% |
| 2006 Q3 | 6.62 Million USD | -2.5% |
| 2006 Q4 | 6.44 Million USD | -2.69% |
| 2005 Q4 | -7.8 Million USD | -14.34% |
| 2005 FY | -7.8 Million USD | -2091.33% |
| 2005 Q1 | -6.44 Million USD | -1744.64% |
| 2005 Q2 | -6.85 Million USD | -6.34% |
| 2005 Q3 | -6.82 Million USD | 0.42% |
| 2004 Q3 | 500 Thousand USD | 0.0% |
| 2004 Q4 | 392 Thousand USD | -21.6% |
| 2004 FY | 392 Thousand USD | -50.13% |
| 2004 Q1 | 653 Thousand USD | -16.92% |
| 2004 Q2 | 500 Thousand USD | -23.43% |
| 2003 FY | 786 Thousand USD | 0.0% |
| 2003 Q4 | 786 Thousand USD | 115.35% |
| 2003 Q1 | -5.71 Million USD | 0.0% |
| 2003 Q3 | -5.12 Million USD | 3.47% |
| 2003 Q2 | -5.3 Million USD | 7.21% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | -100.0% |
| 2000 FY | - USD | -100.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 Q2 | 4.2 Million USD | 0.0% |
| 1999 Q4 | 300 Thousand USD | -92.86% |
| 1999 FY | 300 Thousand USD | -92.86% |
| 1999 Q3 | 4.2 Million USD | 0.0% |
| 1999 Q1 | 4.2 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | 4.2 Million USD | 0.0% |
| 1998 FY | 4.2 Million USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aspira Women's Health Inc. | 1.43 Million USD | -43458.252% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -55590.731% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -765827.647% |
| Standard BioTools Inc. | 3.98 Million USD | -15538.539% |
| Inotiv, Inc. | 399.4 Million USD | -55.951% |
| Prenetics Global Limited | 867.21 Thousand USD | -71725.672% |
| Neuronetics, Inc. | 59.28 Million USD | -950.694% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -54300.262% |
| Castle Biosciences, Inc. | 14.19 Million USD | -4287.118% |
| Psychemedics Corporation | 945 Thousand USD | -65813.545% |
| RadNet, Inc. | 812.06 Million USD | 23.297% |
| Exact Sciences Corporation | 2.47 Billion USD | 74.837% |
| iSpecimen Inc. | 29.13 Thousand USD | -2138186.989% |
| OpGen, Inc. | 2.02 Million USD | -30711.143% |
| Exagen Inc. | 19.23 Million USD | -3138.953% |
| Bionano Genomics, Inc. | 7.17 Million USD | -8581.296% |
| CareDx, Inc | 28.27 Million USD | -2102.712% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 79.17 Million USD | -686.737% |
| Guardant Health, Inc. | 1.13 Billion USD | 45.36% |
| Biodesix, Inc. | 35.22 Million USD | -1668.298% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -630584.568% |
| Precipio, Inc. | 106 Thousand USD | -587525.472% |
| Natera, Inc. | 282.94 Million USD | -120.143% |
| Fulgent Genetics, Inc. | 10.11 Million USD | -6060.449% |
| Sera Prognostics, Inc. | 840 Thousand USD | -74052.738% |
| 23andMe Holding Co. | 67.84 Million USD | -818.097% |
| OPKO Health, Inc. | 222.03 Million USD | -180.535% |
| Personalis, Inc. | 1.23 Million USD | -50376.742% |
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -20162.947% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -84168.807% |
| T2 Biosystems, Inc. | 6.59 Million USD | -9340.482% |
| Neogen Corporation | 888.39 Million USD | 29.886% |
| Myriad Genetics, Inc. | 130.9 Million USD | -375.846% |
| ICON Public Limited Company | 3.66 Billion USD | 83.007% |
| NeoGenomics, Inc. | 606.06 Million USD | -2.774% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -54300.262% |
| MDxHealth SA | 35.56 Million USD | -1651.442% |
| Prenetics Global Limited | 867.21 Thousand USD | -71725.672% |
| Illumina, Inc. | 1.48 Billion USD | 58.168% |
| DarioHealth Corp. | 24.59 Million USD | -2432.971% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -324213.503% |
| Medpace Holdings, Inc. | 142.12 Million USD | -338.273% |
| Mainz Biomed B.V. | 2.19 Million USD | -28265.869% |
| Trinity Biotech plc | 54.65 Million USD | -1039.747% |
| Sotera Health Company | 2.22 Billion USD | 71.989% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -55590.731% |